Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.
about
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responsesHIV-1 Vaccine Trials: Evolving Concepts and DesignsBaseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication.KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.What infants and breasts can teach us about natural protection from HIV infection.Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function.Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infectionAdaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feedingExploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug usersDCs and NK cells: critical effectors in the immune response to HIV-1.Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotypeAntigen-specific NK cell memory in rhesus macaques.Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humansFunctional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection.Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.Enhanced and efficient detection of virus-driven cytokine expression by human NK and T cells.Natural killer cell responses to infections in early life.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).Redefining Memory: Building the Case for Adaptive NK cells.Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth.A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.Alteration of inhibitory and activating natural killer cell receptor expression on T cells in human immunodeficiency virus-infected Chinese.CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.Association of maternal KIR gene content polymorphisms with reduction in perinatal transmission of HIV-1.Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset
P2860
Q28242631-BD495ED6-3448-4747-93BD-C4833DDFEF6DQ30425520-79B83715-8935-4052-BD0D-174F36023E01Q33572705-372C460B-A091-49B2-BC42-06DA179CAF44Q33657935-9F602F57-DA4A-4CB4-AAA9-18FB4FEE539BQ33827994-96CFA2F3-1C63-4FD0-9CB7-ACB60305F20BQ34181863-51D9C8BD-7707-4E64-AB6D-7D50335C3A60Q34634371-F2A4322D-55B2-499B-B20B-EE154BCC8AB7Q34694776-94F33931-4038-4A7F-8EFB-94924B164FCDQ34737407-055D6296-DDDF-4832-9F2F-46AF83B2CD9FQ34869927-9B57F171-B5F3-4D4B-8E3C-E1AB2FC74CC1Q35195360-362B23F2-BC83-4DEF-A1B7-66F94D4976D4Q35660526-7B90E65A-3796-4541-9E19-E884D292AE20Q35752667-EFDA2EE7-3DFB-4D89-BB0C-1E6CA4568972Q35758757-A23F659E-4723-48AE-A166-767D8004E569Q35984239-9C9FDD3B-ED53-449A-A82E-B6AA96025749Q36086748-4310D00C-39B6-4CF8-96D9-0E82E529ED81Q36252656-9641EB8A-06EC-44D1-B6EF-C52E94A7DB69Q36516875-3112A1F7-6F19-4E69-9FF7-9C1A60BAF981Q37426168-C1A91C14-5A8D-4977-B402-517B50B05203Q37505357-EC19EB1A-026B-47DA-8B5E-FA5529476048Q37633921-09562398-0DD7-4CC3-A66A-821C0D66B08CQ37853786-2419C469-65D5-42FC-911E-C225D5BA16B3Q37854081-AAEE91EE-795A-4EF6-A6B0-B873139570FAQ38631761-FBE2D0F8-AA8E-4AE4-BEA2-F0858C066B7FQ41519074-D9FAFF15-5615-4F3C-B76D-3F7702685602Q42214247-A6991AA1-6732-4808-9372-2E64F9C19EAAQ43743967-0FFFF52F-CEC0-4EDA-803F-CB1234554B25Q45364508-746AF826-7BBF-408A-B758-A7BC9E158BB8Q47263250-4B13F03F-B319-4B45-95EA-A0474F4ABA26Q47549870-89589C5A-6534-4473-AAD6-43FC28BF428CQ58290930-F416AB37-8D33-49B5-A0A6-6278670C0B4F
P2860
Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@ast
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@en
type
label
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@ast
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@en
prefLabel
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@ast
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@en
P2093
P2860
P356
P1476
Cutting Edge: Unusual NK cell ...... -infant transmission of HIV-1.
@en
P2093
Ashraf H Coovadia
Caroline T Tiemessen
Diana B Schramm
Gayle G Sherman
Glenda E Gray
Maria A Papathanasopoulos
Sharon Shalekoff
P2860
P304
P356
10.4049/JIMMUNOL.0900419
P407
P577
2009-05-01T00:00:00Z